ALCN Stock Overview
Atlantic Central Enterprise Ltd., through its subsidiary Vista Technologies, Inc., provides photorefractive keratectomy and other laser vision correction facilities and services to the healthcare industry.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Atlantic Central Enterprise Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0002 |
52 Week High | US$0.0002 |
52 Week Low | US$0.0001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | 19,900.00% |
Change since IPO | -99.98% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
ALCN | US Healthcare | US Market | |
---|---|---|---|
7D | 0% | -0.8% | 2.9% |
1Y | n/a | 1.7% | 22.2% |
Return vs Industry: Insufficient data to determine how ALCN performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how ALCN performed against the US Market.
Price Volatility
ALCN volatility | |
---|---|
ALCN Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 7.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ALCN has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ALCN's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | n/a | Patrick Rooney | n/a |
Atlantic Central Enterprise Ltd., through its subsidiary Vista Technologies, Inc., provides photorefractive keratectomy and other laser vision correction facilities and services to the healthcare industry. It primarily operates in the United States and western Europe. The company was formerly known as Bamburgh Limited and changed its name to Atlantic Central Enterprise Ltd.
Atlantic Central Enterprise Ltd. Fundamentals Summary
ALCN fundamental statistics | |
---|---|
Market cap | US$532.00 |
Earnings (TTM) | -US$12.55m |
Revenue (TTM) | US$3.49m |
0.0x
P/S Ratio0.0x
P/E RatioIs ALCN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ALCN income statement (TTM) | |
---|---|
Revenue | US$3.49m |
Cost of Revenue | US$0 |
Gross Profit | US$3.49m |
Other Expenses | US$16.03m |
Earnings | -US$12.55m |
Last Reported Earnings
Feb 28, 1997
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did ALCN perform over the long term?
See historical performance and comparison